Trials / Terminated
TerminatedNCT02905617
Post Market Clinical Experience Study of Sientra 207 Breast Implants
Post Market Clinical Experience Study of the Sientra 207 High-Strength Cohesive Plus (HSC+) Breast Implants in Primary and Revision Augmentation Participants
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 113 (actual)
- Sponsor
- Tiger Biosciences, LLC. · Industry
- Sex
- Female
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
A 12-month study to evaluate the clinical experience with Sientra 207 Silicone Gel Breast Implants
Detailed description
This study is designed to prospectively collect surgeon and participant satisfaction with the Sientra 207 implants in primary and revision augmentation participants over a 12-month time frame.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sientra 207 Silicone Gel Breast Implant | The Sientra 207 Silicone Gel Breast Implant is a textured, round device with high-strength cohesive plus (HSC+) silicone gel fill. |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2020-07-15
- Completion
- 2020-07-15
- First posted
- 2016-09-19
- Last updated
- 2023-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02905617. Inclusion in this directory is not an endorsement.